Literature DB >> 17696779

Diversity of proteasomal missions: fine tuning of the immune response.

Ljudmila Borissenko1, Michael Groll.   

Abstract

The majority of cellular proteins are degraded by proteasomes within the ubiquitin-proteasome ATP-dependent degradation pathway. Products of proteasomal activity are short peptides that are further hydrolysed by proteases to single amino acids. However, some peptides can escape this degradation, being selected and taken up by major histocompatibility complex (MHC) class I molecules for presentation to the immune system on the cell surface. MHC class I molecules are highly selective and specific in terms of ligand binding. Variability of peptides produced in living cells arises in a variety of ways, ensuring fast and efficient immune responses. Substitution of constitutive proteasomal subunits with immunosubunits leads to conformational changes in the substrate binding channels, resulting in a modified protein cleavage pattern and consequently in the generation of new antigenic peptides. The recently discovered event of proteasomal peptide splicing opens new horizons in the understanding of additional functions that proteasomes apparently possess. Whether peptide splicing is an occasional side product of proteasomal activity still needs to be clarified. Both gamma-interferon-induced immunoproteasomes and peptide splicing represent two significant events providing increased diversity of antigenic peptides for flexible and fine-tuned immune response.

Mesh:

Substances:

Year:  2007        PMID: 17696779     DOI: 10.1515/BC.2007.109

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

Review 1.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Hugo D Meiring; Lennert Janssen; Jacques J Neefjes; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

3.  Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage.

Authors:  Celia R Berkers; Annemieke de Jong; Karianne G Schuurman; Carsten Linnemann; Jan A J Geenevasen; Ton N M Schumacher; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2015-09-23       Impact factor: 5.422

4.  Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Sunita Gupta; Jeffrey N Keller; Pamela E Knapp; Kurt F Hauser; Annadora J Bruce-Keller
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

5.  Driving forces of proteasome-catalyzed peptide splicing in yeast and humans.

Authors:  Michele Mishto; Andrean Goede; Kathrin Textoris Taube; Christin Keller; Katharina Janek; Petra Henklein; Agathe Niewienda; Alexander Kloss; Sabrina Gohlke; Burkhardt Dahlmann; Cordula Enenkel; Peter Michael Kloetzel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

6.  The 20S proteasome splicing activity discovered by SpliceMet.

Authors:  Juliane Liepe; Michele Mishto; Kathrin Textoris-Taube; Katharina Janek; Christin Keller; Petra Henklein; Peter Michael Kloetzel; Alexey Zaikin
Journal:  PLoS Comput Biol       Date:  2010-06-24       Impact factor: 4.475

7.  Network, degeneracy and bow tie. Integrating paradigms and architectures to grasp the complexity of the immune system.

Authors:  Paolo Tieri; Andrea Grignolio; Alexey Zaikin; Michele Mishto; Daniel Remondini; Gastone C Castellani; Claudio Franceschi
Journal:  Theor Biol Med Model       Date:  2010-08-11       Impact factor: 2.432

8.  Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes.

Authors:  Juliane Liepe; Hermann-Georg Holzhütter; Elena Bellavista; Peter M Kloetzel; Michael P H Stumpf; Michele Mishto
Journal:  Elife       Date:  2015-09-22       Impact factor: 8.140

9.  Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.

Authors:  F Ebstein; K Textoris-Taube; C Keller; R Golnik; N Vigneron; B J Van den Eynde; B Schuler-Thurner; D Schadendorf; F K M Lorenz; W Uckert; S Urban; A Lehmann; N Albrecht-Koepke; K Janek; P Henklein; A Niewienda; P M Kloetzel; M Mishto
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

Review 10.  Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy.

Authors:  Honglin Luo; Jerry Wong; Brian Wong
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.